The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Aptevo Therapeutics Inc(NASDAQ:APVO)


Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1/1b clinic...
Website: http://aptevotherapeutics.com
Founded: 2016
Full Time Employees: 80
Sector: Healthcare
Industry: Biotechnology
Aptevo Therapeutics Days Payable Outstanding ttm (DPO)
Aptevo Therapeutics Op Cashflow Per Share ttm
Aptevo Therapeutics Free Cashflow Per Share ttm
Aptevo Therapeutics Cash Per Share ttm
Aptevo Therapeutics P/S ratio ttm
Aptevo Therapeutics (GAAP) P/E ratio ttm
Aptevo Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.